Abiopharma

News list

Director Sun Kang 🟢 acquired 6.2K shares of Amprius Technologies, Inc. (AMPX) Transaction Date: May 05, 2026 | Filing ID: 000017

Full text

News bot May 7, 2026, 8:52 p.m.
🔍 Sun Kang (Director)

Company: Amprius Technologies, Inc. (AMPX)

Report Date: 2026-05-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 6,250
Detailed Transactions and Holdings:
- Acquired 6,250 shares of Common stock (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,348,650.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The securities are represented by restricted stock units. Each restricted stock unit represents the reporting person's right to receive one share of the issuer's common stock. 1/8th of shares subject to award will vest on May 20, 2026 and quarterly thereafter on each August 20, November 20, February 20 and May 20, subject to the reporting person's continued service on each such date, until the award is fully vested on February 20, 2028.
- F2: Includes 1,165,635 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.